Should we adjust substance use disorder treatment for depressed adolescents?

November 20, 2014, Taylor & Francis

Although depression and substance use disorders commonly co-occur in adolescents, little is known about how depression influences adolescent substance use disorder treatment retention and outcomes.  With this issue in mind, a team of American researchers reviewed the available scientific literature and suggested four important considerations to maximize the clinical impact of future research regarding adolescent depression symptoms and substance use.  Their review is published in the newest special issue of Substance Abuse journal.

In the review, the researchers noted the mixed results of a total of thirteen quantitative studies investigating whether and how depression is associated with substance-related outcomes.  "Our review highlights that studies to date varied widely in hypotheses and research methods, suggesting that the field needs to develop more standardized methods to allow for a clearer understanding of the role of comorbid depression among adolescents in ," wrote the researchers in a joint statement.

To avoid future ambiguities within clinical research, the researchers provide four considerations to inform study design.  First, researchers must consider the time frame for assessing , such as measuring symptoms at both the beginning and end of treatment and distinguishing between lifetime versus current symptoms. A second consideration pertains to the debate about whether to address comorbid depression within treatment, and if so, how. Measuring comorbid symptoms at the beginning and end of treatment even when depression is not specifically addressed during treatment would help to answer this question. Third, it is also important to assess comorbidity both dimensionally (i.e., severity level) and categorically (i.e., meets criteria for a disorder) in order to fully understand the effects of depression on treatment success.  Fourth, researchers should consider the timing of comorbid symptoms relative to the since substance use disorders can occur before, after, or simultaneously with the onset of depression.

"Clarification based on rigorous research studies will permit researchers to identify the conditions under which depression can influence substance abuse treatment retention and outcomes, which in turn will help to specify when needs to be directly addressed with this population of young people," explained the researchers.

Explore further: Combined depression, substance abuse linked to lower income

More information: Jacqueline Hersh, John F. Curry & Yifrah Kaminer, "What is the Impact of Comorbid Depression on Adolescent Substance Abuse Treatment?" Substance Abuse, DOI: 10.1080/08897077.2014.956164

Related Stories

Combined depression, substance abuse linked to lower income

November 14, 2014
(Medical Xpress)—Young adults with co-occurring depression and substance abuse have a higher likelihood of being unemployed and having lower income in midlife than those with neither disorder, according to a study by Dr. ...

Mapping the future of adolescent substance use treatment

November 17, 2014
Adolescent substance use treatment is at a critical turning point – treatment success is short-lived and the field lacks a definitive best approach. Researchers from the University of Pittsburgh conducted a comprehensive ...

Study details risk factors for substance use disorders after manic episode

July 22, 2014
(Medical Xpress)—Adolescents with bipolar disorder are more likely to develop substance use disorders than adolescents without psychiatric disorders. Now, researchers at the University of Cincinnati (UC) have identified ...

Cognitive behavioral therapy may benefit patients in residential substance abuse treatment programs

June 6, 2011
Patients in residential treatment programs for drug and alcohol abuse may benefit from cognitive behavioral therapy for depressive symptoms, according to a report in the June issue of Archives of General Psychiatry.

Treatment of substance abuse can lessen risk of future violence in mentally ill, study finds

October 1, 2014
If a person is dually diagnosed with a severe mental illness and a substance abuse problem, are improvements in their mental health or in their substance abuse most likely to reduce the risk of future violence?

Collaborative care improves depression in teens

August 26, 2014
How best to care for the many adolescents who have depression? In a collaborative care intervention, a care manager continually reached out to teens—delivering and following up on treatment in a primary-care setting (the ...

Recommended for you

New research finds drug for alcohol use disorder ineffective

February 26, 2018
A new study, published in the Addiction journal, conducted by researchers from the University of Liverpool highlights the ineffectiveness of a specific drug treatment for alcohol use disorders.

Most PA students tobacco-free, but vaping and cigarette use still a concern

February 26, 2018
Most of Pennsylvania's high school and middle school students are tobacco-free, but the use of cigarettes, and their digital counterpart, e-cigarettes, is still a cause for concern, according to Penn State researchers.

Cannabinoids are easier on the brain than booze, study finds

February 9, 2018
Marijuana may not be as damaging to the brain as previously thought, according to new research from the University of Colorado Boulder and the CU Change Lab.

Marijuana use may not aid patients in opioid addiction treatment

December 4, 2017
Many patients who are being treated for opioid addiction in a medication-assisted treatment clinic use marijuana to help manage their pain and mood symptoms.

For opiate addiction, study finds drug-assisted treatment is more effective than detox

November 23, 2017
Say you're a publicly insured Californian with an addiction to heroin, fentanyl or prescription narcotics, and you want to quit.

Study finds medical cannabis is effective at reducing opioid addiction

November 17, 2017
A new study conducted by researchers at The University of New Mexico, involving medical cannabis and prescription opioid use among chronic pain patients, found a distinct connection between having the legal ability to use ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.